Evidence map›Paper›PMID 25201077›Full record

Trial reportJournal of proteomics2015

Proteomics of apheresis platelet supernatants during routine storage: Gender-related differences.

Monika Dzieciatkowska, Angelo D'Alessandro, Timothy A Burke, Marguerite R Kelher, Ernest E Moore, Anirban Banerjee, Christopher C Silliman, Bernadette F West, Kirk C Hansen

Open access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Journal of proteomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Observational
  5. Omics markers of the red cell storage lesion and metabolic linkage.Blood transfusion = Trasfusione del sangue · 2017
    Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Monika DzieciatkowskaBiochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States.
Angelo D'AlessandroBiochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States.
Timothy A BurkeBonfils Blood Center, Denver, CO, United States.
Marguerite R KelherBonfils Blood Center, Denver, CO, United States.
Ernest E MooreSurgery, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States.
Anirban BanerjeePediatrics, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States.
Christopher C SillimanBonfils Blood Center, Denver, CO, United States; Surgery, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States; Pediatrics, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States.
Bernadette F WestBonfils Blood Center, Denver, CO, United States.
Kirk C HansenBiochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States. Electronic address: kirk.hansen@UCDenver.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Trauma Reprograms CellsP50GM049222 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI BANERJEE, ANIRBAN · 1993 to 2017
$26.1M
Mechanisms of Trauma-Induced CoagulopathyT32GM008315 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Mitchell Cohen, ELIZABETH J. KOVACS · 1991 to 2026
$7.1M
LTQ FT-ICR Hybrid Mass Spectrometer PurchaseS10RR023015 · NCRR · UNIVERSITY OF COLORADO DENVER · PI HANSEN, KIRK C · 2007 to 2007
$1.1M
NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1TR001082NCRR NIH HHS S10 RR023015NCRR NIH HHS S10RR023015NIGMS NIH HHS P50 GM049222NIGMS NIH HHS P50-GM049222NIGMS NIH HHS T32 GM008315NIGMS NIH HHS T32-GM008315
6 · The paper itself

Abstract

Proteomics has identified potential pathways involved in platelet storage lesions, which correlate with untoward effects in the recipient, including febrile non-haemolytic reactions. We hypothesize that an additional pathway involves protein mediators that accumulate in the platelet supernatants during routine storage in a donor gender-specific fashion. Apheresis platelet concentrates were collected from 5 healthy males and 5 females and routinely stored. The 14 most abundant plasma proteins were removed and the supernatant proteins from days 1 and 5 were analyzed via 1D-SDS-PAGE/nanoLC-MS/MS, before label-free quantitative proteomics analyses. Findings from a subset of 18 proteins were validated via LC-SRM analyses against stable isotope labeled standards. A total of 503 distinct proteins were detected in the platelet supernatants from the 4 sample groups: female or male donor platelets, either at storage day 1 or 5. Proteomics suggested a storage and gender-dependent impairment of blood coagulation mediators, pro-inflammatory complement components and cytokines, energy and redox metabolic enzymes. The supernatants from female donors demonstrated increased deregulation of structural proteins, extracellular matrix proteins and focal adhesion proteins, possibly indicating storage-dependent platelet activation. Routine storage of platelet concentrates induces changes in the supernatant proteome, which may have effects on the transfused patient, some of which are related to donor gender. BIOLOGICAL SIGNIFICANCE: The rationale behind this study is that protein components in platelet releasates have been increasingly observed to play a key role in adverse events and impaired homeostasis in transfused recipients. In this view, proteomics has recently emerged as a functional tool to address the issue of protein composition of platelet releasates from buffy coat-derived platelet concentrates in the blood bank. Despite early encouraging studies on buffy coat-derived platelet concentrates, platelet releasates from apheresis platelets have not been hitherto addressed by means of extensive proteomics technologies. Indeed, apheresis platelets are resuspended in donors' plasma, which hampers detection of less abundant proteins, owing to the overwhelming abundance of albumin (and a handful of other proteins), and the dynamic range of protein concentrations of plasma proteins. In order to cope with these issues, we hereby performed an immuno-affinity column-based depletion of the 14 most abundant plasma proteins. Samples were thus assayed via GeLC-MS, a workflow that allowed us to cover an unprecedented portion of the platelet supernatant proteome, in comparison to previous transfusion medicine-oriented studies in the literature. Finally, we hereby address the issue of biological variability, by considering the donor gender as a key factor influencing the composition of apheresis platelet supernatants. As a result, we could conclude that platelet supernatants from male and female donors are not only different in the first place, but they also store differently. This conclusion has been so far only suggested by classic transfusion medicine studies, but has been hitherto unsupported by actual biochemistry/proteomics investigations. In our opinion, the main strengths of this study are related to the analytical workflow (immunodepletion and GeLC-MS) and proteome coverage, the translational validity of the results (from a transfusion medicine standpoint) and the biological conclusion about the intrinsic (and storage-dependent) gender-related differences of platelet supernatants.

Indexed as

Blood PreservationPlateletpheresisProteomicsSex CharacteristicsBlood PlateletsBlood ProteinsFemaleHumansMaleMiddle AgedBlood ProteinsDonorHumanLabel-free quantitationMass spectrometryProteomicsTransfusion medicine

Identifiers

PMID25201077
PMCPMC5203985
OpenAlexW2053253045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.